• CloudMD (DOC) has appointed a new Vice President, Clinic Operations to integrate and lead its current network of clinics
  • Kristine Heckman will also focus on driving expansion across every province of Canada and strategically in the United States
  • Heckman brings over 20 years of industry experience
  • In her role with Lifemark Health, she was responsible for managing and leading the operations and financial performance of their multidisciplinary clinic network across British Columbia
  • CloudMD is down 1.19 per cent to C$2.49 per share

CloudMD (DOC) has appointed a new Vice President, Clinic Operations to integrate and lead its current network of clinics.

Kristine Heckman will also focus on driving expansion across every province of Canada and strategically in the United States.

CloudMD CEO Essam Hamza said the company is delighted to welcome Heckman to its leadership team as VP, Clinic Operations.

“CloudMD has achieved significant growth in a very short amount of time, and as we continue to establish the foundation to expand the business, Kristine will be a key leadership pillar for our clinical division,” Hamza said.

Heckman brings over 20 years of industry experience, most recently as VP, Clinic Operations with Lifemark Health, a national rehabilitation company with over 200 locations across Canada.

In her role with Lifemark Health, she was responsible for managing and leading the operations and financial performance of their multidisciplinary clinic network across British Columbia.

Heckman was also responsible for supporting growth and expansion through M&A activities and integrating new clinics into Lifemark Health’s existing network.

She was accountable for establishing and adhering to best practice quality of care standards and customer satisfaction as well as executing new corporate initiatives to ensure execution of standard operating procedures.

CloudMD’s current clinic network includes 14 clinics, 95 practitioners servicing over 500,000 patients.

CloudMD is down 1.19 per cent to C$2.49 per share at 11:41 am EST.

More From The Market Online

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.